{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T08:02:22Z","timestamp":1791619342055,"version":"4.3.4"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903393, 81903398"],"award-info":[{"award-number":["81903393, 81903398"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Genetic studies have linked polymorphisms in the interleukin 6 receptor (<jats:italic>IL6R<\/jats:italic>) gene to the risk of multiple human diseases and phenotypes, yet have reported inconsistent results. We aimed to synthesize current knowledge of variants in the <jats:italic>IL6R<\/jats:italic> gene on the risk of diseases and phenotypes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We searched the Medline and Embase databases to identify relevant publications. Meta-analysis was performed utilizing DerSimonian and Laird random-effects model. We also graded cumulative evidence for significant associations. Furthermore, phenome-wide analyses and functional annotations were performed for variants with strong evidence.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We included 155 studies for evaluating the associations between 80 polymorphisms in the <jats:italic>IL6R<\/jats:italic> gene and the risk of 102 human diseases and 98 phenotypes. We conducted 58 main meta-analyses, and 41 significant associations were identified. Strong evidence was assigned to 29 associations that investigated ten variants (rs2228145, rs4129267, rs7529229, rs4537545, rs7518199, rs4845625, rs4553185, rs4845618, rs4845371, and rs6667434) related to the risk of four cardiovascular diseases (coronary heart disease, coronary artery disease, atherosclerosis, and abdominal aortic aneurysms), four inflammatory diseases (rheumatoid arthritis, Crohn\u2019s disease, dermatitis, and asthma), and concentration of four phenotypes (C-reactive protein, fibrinogen, IL-6, and sIL-6R). Furthermore, phenome-wide analysis verified that rs2228145 associated with asthma and dermatitis risk. Functional analyses indicated that these polymorphisms fall within exon, enhancer regions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our study comprehensively summarizes current data on the genetic architecture of the <jats:italic>IL6R<\/jats:italic> gene and highlights the pharmacological targeting potential of IL-6R on cardiovascular and inflammatory diseases.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.860703","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T07:38:13Z","timestamp":1649921893000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Cumulative Evidence for Associations Between Genetic Variants in Interleukin 6 Receptor Gene and Human Diseases and Phenotypes"],"prefix":"10.3389","volume":"13","author":[{"given":"Min","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijie","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingshuang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanbing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqing","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s10519-014-9656-8","article-title":"The Contribution of the Functional IL6R Polymorphism Rs2228145, eQTLs and Other Genome-Wide SNPs to the Heritability of Plasma sIL-6R Levels","volume":"44","author":"van Dongen","year":"2014","journal-title":"Behav Genet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fsi.2018.12.031","article-title":"Molecular Characterization of Grass Carp Interleukin-6 Receptor and the Agonistic Activity of Its Soluble Form in Head Kidney Leucocytes","volume":"86","author":"Wang","year":"2019","journal-title":"Fish Shellfish Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1042\/cs20110340","article-title":"IL-6\/IL-6 Receptor System and its Role in Physiological and Pathological Conditions","volume":"122","author":"Mihara","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27127","article-title":"Correlation Between Interleukin Gene Polymorphisms and Current Prevalence and Mortality Rates Due to Novel Coronavirus Disease 2019 (COVID-2019) in 23 Countries","volume":"93","author":"Karcioglu Batur","year":"2021","journal-title":"J Med Virol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/humu.9130","article-title":"Identification of Novel SNPs in the Interleukin 6 Receptor Gene (IL6R)","volume":"21","author":"Kim","year":"2003","journal-title":"Hum Mutat"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2003.07.003","article-title":"Variants in the Interleukin 6 Receptor Gene Are Associated With Obesity in Pima Indians","volume":"80","author":"Wolford","year":"2003","journal-title":"Mol Genet Metab"},{"key":"B7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1053\/j.gastro.2018.05.022","article-title":"Variation in Interleukin 6 Receptor Gene Associates With Risk of Crohn\u2019s Disease and Ulcerative Colitis","volume":"155","author":"Parisinos","year":"2018","journal-title":"Gastroenterology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2462","article-title":"High-Density Genetic Mapping Identifies New Susceptibility Loci for Rheumatoid Arthritis","volume":"44","author":"Eyre","year":"2012","journal-title":"Nat Genet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61931-4","article-title":"Interleukin-6 Receptor Pathways in Coronary Heart Disease: A Collaborative Meta-Analysis of 82 Studies","volume":"379","author":"Sarwar","year":"2012","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60110-X","article-title":"The Interleukin-6 Receptor as a Target for Prevention of Coronary Heart Disease: A Mendelian Randomisation Analysis","volume":"379","author":"Swerdlow","year":"2012","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.12.3342","article-title":"Variation in the Interleukin-6 Receptor Gene Associates With Type 2 Diabetes in Danish Whites","volume":"53","author":"Hamid","year":"2004","journal-title":"Diabetes"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003444","article-title":"Functional IL6R 358Ala Allele Impairs Classical IL-6 Receptor Signaling and Influences Risk of Diverse Inflammatory Diseases","volume":"9","author":"Ferreira","year":"2013","journal-title":"PloS Genet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2018.2287","article-title":"Association of Interleukin 6 Receptor Variant With Cardiovascular Disease Effects of Interleukin 6 Receptor Blocking Therapy: A Phenome-Wide Association Study","volume":"3","author":"Cai","year":"2018","journal-title":"JAMA Cardiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2017.170216","article-title":"Interleukin 6 Receptor (IL6-R) Gene Polymorphisms Underlie Susceptibility to Rheumatoid Arthritis","volume":"63","author":"Ahmed","year":"2017","journal-title":"Clin Lab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60874-X","article-title":"Identification of IL6R and Chromosome 11q13.5 as Risk Loci for Asthma","volume":"378","author":"Ferreira","year":"2011","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/ng.2480","article-title":"Large-Scale Association Analysis Identifies New Risk Loci for Coronary Artery Disease","volume":"45","author":"Deloukas","year":"2013","journal-title":"Nat Genet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.110.959197","article-title":"Large-Scale Candidate Gene Analysis in Whites and African Americans Identifies IL6R Polymorphism in Relation to Atrial Fibrillation: The National Heart, Lung, and Blood Institute\u2019s Candidate Gene Association Resource (CARe) Project","volume":"4","author":"Schnabel","year":"2011","journal-title":"Circ Cardiovasc Genet"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1089\/gtmb.2015.0169","article-title":"Association of IL-6 Promoter and Receptor Polymorphisms With Multiple Myeloma Risk: A Systematic Review and Meta-Analysis","volume":"20","author":"Li","year":"2016","journal-title":"Genet Test Mol Biomarkers"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs354","article-title":"Interleukin-6 Receptor Pathways in Abdominal Aortic Aneurysm","volume":"34","author":"Harrison","year":"2013","journal-title":"Eur Heart J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/504727","article-title":"An Association Study Between Genetic Polymorphism in the Interleukin-6 Receptor Gene and Coronary Heart Disease","volume":"2014","author":"Zhou","year":"2014","journal-title":"BioMed Res Int"},{"key":"B21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3371\/CSRP.HUMI.070516","article-title":"Meta-Analysis of Cytokine and Chemokine Genes in Schizophrenia","volume":"12","author":"Hudson","year":"2018","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1371\/journal.pmed.1000028","article-title":"Systematic Reviews of Genetic Association Studies. Human Genome Epidemiology Network","volume":"6","author":"Sagoo","year":"2009","journal-title":"PloS Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7647","article-title":"Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015: Elaboration and Explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"B24","doi-asserted-by":"publisher","first-page":"4048","DOI":"10.1038\/s41598-017-03692-y","article-title":"Meta-Analysis of Soy Consumption and Gastrointestinal Cancer Risk","volume":"7","author":"Lu","year":"2017","journal-title":"Sci Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-9-199711010-00008","article-title":"Quantitative Synthesis in Systematic Reviews","volume":"127","author":"Lau","year":"1997","journal-title":"Ann Intern Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186","article-title":"Quantifying Heterogeneity in a Meta-Analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2307\/2533446","article-title":"Operating Characteristics of a Rank Correlation Test for Publication Bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in Meta-Analysis Detected by a Simple, Graphical Test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dym159","article-title":"Assessment of Cumulative Evidence on Genetic Associations: Interim Guidelines","volume":"37","author":"Ioannidis","year":"2008","journal-title":"Int J Epidemiol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh075","article-title":"Assessing the Probability That a Positive Report Is False: An Approach for Molecular Epidemiology Studies","volume":"96","author":"Wacholder","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"B31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature11632","article-title":"An Integrated Map of Genetic Variation From 1,092 Human Genomes","volume":"491","author":"Abecasis","year":"2012","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0248-z","article-title":"An Atlas of Genetic Associations in UK Biobank","volume":"50","author":"Canela-Xandri","year":"2018","journal-title":"Nat Genet"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr917","article-title":"HaploReg: A Resource for Exploring Chromatin States, Conservation, and Regulatory Motif Alterations Within Sets of Genetically Linked Variants","volume":"40","author":"Ward","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1020","article-title":"The UCSC Genome Browser Database: 2018 Update","volume":"46","author":"Casper","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2756","article-title":"Systematic Identification of Trans eQTLs as Putative Drivers of Known Disease Associations","volume":"45","author":"Westra","year":"2013","journal-title":"Nat Genet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1126\/science.1262110","article-title":"Human Genomics. The Genotype-Tissue Expression (GTEx) Pilot Analysis: Multitissue Gene Regulation in Humans","volume":"348","year":"2015","journal-title":"Science"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.782","article-title":"The Soluble Interleukin 6 Receptor: Advanced Therapeutic Options in Inflammation","volume":"102","author":"Rose-John","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"B38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12964-018-0268-4","article-title":"Activation of the JAK\/STAT3 and PI3K\/AKT Pathways Are Crucial for IL-6 Trans-Signaling-Mediated Pro-Inflammatory Response in Human Vascular Endothelial Cells","volume":"16","author":"Zegeye","year":"2018","journal-title":"Cell Commun Signal"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2014.05.018","article-title":"The Interleukin-6 Receptor Asp358Ala Single Nucleotide Polymorphism Rs2228145 Confers Increased Proteolytic Conversion Rates by ADAM Proteases","volume":"1842","author":"Garbers","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201512-2368OC","article-title":"Therapeutic Targeting of the IL-6 Trans-Signaling\/Mechanistic Target of Rapamycin Complex 1 Axis in Pulmonary Emphysema","volume":"194","author":"Ruwanpura","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2016.03.026","article-title":"The IL6R Gene Polymorphisms Are Associated With sIL-6r, IgE and Lung Function in Chinese Patients With Asthma","volume":"585","author":"Wang","year":"2016","journal-title":"Gene"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3168\/jds.2012-6514","article-title":"Oral Administration of Lactobacillus Delbrueckii Subspecies Bulgaricus OLL1073R-1 Suppresses Inflammation by Decreasing Interleukin-6 Responses in a Murine Model of Atopic Dermatitis","volume":"96","author":"Kano","year":"2013","journal-title":"J Dairy Sci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/dddt.S150580","article-title":"Tocilizumab in the Treatment of Rheumatoid Arthritis: An Evidence-Based Review and Patient Selection","volume":"13","author":"Biggioggero","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2013.09.004","article-title":"Targeting Interleukin-6 in Inflammatory Autoimmune Diseases and Cancers","volume":"141","author":"Yao","year":"2014","journal-title":"Pharmacol Ther"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102568","article-title":"Tocilizumab for the Treatment of Severe COVID-19 Pneumonia With Hyperinflammatory Syndrome and Acute Respiratory Failure: A Single Center Study of 100 Patients in Brescia, Italy","volume":"19","author":"Toniati","year":"2020","journal-title":"Autoimmun Rev"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.860703\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T07:38:16Z","timestamp":1649921896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.860703\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,14]]},"references-count":45,"alternative-id":["10.3389\/fimmu.2022.860703"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.860703","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,14]]},"article-number":"860703"}}